288 related articles for article (PubMed ID: 7491235)
1. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
[TBL] [Abstract][Full Text] [Related]
5. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
6. Neonatal administration of rhesus rotavirus tetravalent vaccine.
Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
[TBL] [Abstract][Full Text] [Related]
7. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
[TBL] [Abstract][Full Text] [Related]
10. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
11. Tetravalent human-rhesus reassortant rotavirus vaccine: a review of its immunogenicity, tolerability and protective efficacy against paediatric rotavirus gastroenteritis.
Foster RH; Wagstaff AJ
BioDrugs; 1998 Feb; 9(2):155-78. PubMed ID: 18020551
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
Ward RL; Bernstein DI
Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.
Goveia MG; DiNubile MJ; Dallas MJ; Heaton PM; Kuter BJ;
Pediatr Infect Dis J; 2008 Jul; 27(7):656-8. PubMed ID: 18520448
[TBL] [Abstract][Full Text] [Related]
15. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
Rennels MB; Ward RL; Mack ME; Zito ET
J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
[TBL] [Abstract][Full Text] [Related]
16. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group.
Ward RL; Knowlton DR; Zito ET; Davidson BL; Rappaport R; Mack ME
J Infect Dis; 1997 Sep; 176(3):570-7. PubMed ID: 9291301
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological studies of rotavirus vaccines.
Vesikari T
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]